Federal Supply Schedule 36F79723D021E
Award Date
1/1/23
Last Date to Order
6/30/23
Federal Agency
Veterans Integrated Service Network 12
Awardee
Enzyvant Therapeutics Inc.
Ultimate Awardee
Not listed
NAICS Category
325412 - Pharmaceutical Preparation Manufacturing
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Pricing Type
Fixed Price with Economic Price Adjustment
Legislative Mandate
Not listed
National Interest Action
None
Award Type
Multiple
Primary Consortia Member
Not listed
Similar IDVs
This Federal Supply Schedule (FSS) contract was awarded by the U.S. Department of Veterans Affairs (VA) to H2-Pharma LLC, a for-profit limited liability company, to provide pharmaceuticals and hematology-related products. The contract has a ceiling value of $225,000.00 and a period of performance from October 1, 2018 to October 1, 2025. The FSS contract, part of the Pharmaceuticals and Drugs (FSS-61-IB) schedule, is a multiple award vehicle that allows federal agencies to procure the...
This Federal Supply Schedule (FSS) contract, awarded by the U.S. Department of Veterans Affairs (VA) to Alnylam Pharmaceuticals, Inc., covers the procurement of pharmaceutical and hematology-related products under FSS-61-IB. The contract has a ceiling value of $4,149,600.00 and a period of performance from February 1, 2019 to March 1, 2026. As a multiple award FSS contract, it provides a mechanism for the VA and other federal agencies to purchase a variety of pharmaceutical and drug products...
This is a multiple award Federal Supply Schedule (FSS) contract awarded by the Department of Veterans Affairs (VA) to Invivyd, Inc. for the procurement of drugs, pharmaceuticals, and hematology related products under Schedule 65 I B. The contract has a ceiling value of $25,000.00 and a period of performance through November 14, 2024. As a Federal Supply Schedule contract, this agreement provides a streamlined procurement vehicle for federal agencies to acquire the covered pharmaceutical and...
This Federal Supply Schedule (FSS) contract was awarded by the Department of Veterans Affairs (VA) to Ascend Therapeutics US LLC, a foreign-owned for-profit organization. The $25,000 interim agreement is under FSS Schedule 65 I B for Drugs, Pharmaceuticals, & Hematology Related Products, with a period of performance through September 14, 2023. As a multiple award contract, this FSS provides the VA with a pre-negotiated list of products and services that can be ordered as needed. The scope of...
This Federal Supply Schedule (FSS) contract was awarded by the Department of Veterans Affairs (VA) to NS Pharma, Inc., a foreign-owned for-profit manufacturer of pharmaceutical and hematology-related products. The contract, with a ceiling value of $225,000, has an ultimate completion date of March 14, 2026 and was originally awarded on March 15, 2021. The scope of the contract includes the provision of "Drugs, Pharmaceuticals, & Hematology Related Products" under the GSA Schedule...
The Federal Supply Schedule (FSS) contract 36F79718D0461 was awarded to Prime Contractor Para Pro LLC, a small disadvantaged business and veteran-owned manufacturer of goods, to provide pharmaceuticals and related hematology products. The contract has a $250,000 ceiling value and a performance period ending on May 31, 2025. This multiple award FSS contract falls under the Pharmaceuticals and Drugs (FSS-61-IB) master schedule and was awarded by the Department of Veterans Affairs, Veterans...
This Federal Supply Schedule (FSS) contract, awarded by the Department of Veterans Affairs (VA) to Exela Pharma Sciences LLC, is for the procurement of pharmaceuticals, drugs, and hematology-related products under FSS-61-IB. The contract has a ceiling value of $3,030,000.00 and a period of performance through September 28, 2024. As a multiple-award schedule contract, this FSS allows the VA and other eligible federal agencies to issue task orders for a wide range of pharmaceutical and drug...
This Federal Supply Schedule (FSS) contract award to Shield Therapeutics Inc. by the Department of Veterans Affairs (VA) is for the provision of pharmaceutical and drug products under the Pharmaceuticals and Drugs (FSS-61-IB) master GSA schedule. The $225,000 ceiling value contract has a base period of performance through March 14, 2027. As a multiple award schedule, this contract allows the VA and other eligible federal agencies to procure the contracted pharmaceuticals and related hematology...
The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 12 awarded a Federal Supply Schedule (FSS) contract to Genericus, Inc. under the Pharmaceuticals and Drugs (FSS-61-IB) FSS master schedule. The contract, valued at up to $225,000.00, enables the procurement of drugs, pharmaceuticals, and hematology-related products. As an FSS contract, this is a multiple award vehicle that allows for indefinite delivery of the specified products and services...
This Federal Supply Schedule contract was awarded by the Veterans Integrated Service Network 12 (VISN 12), a civilian federal agency, to ITF Therapeutics LLC, a foreign-owned, self-certified small disadvantaged business. The contract is for INTERIM AGREEMENT UNDER FSS SCHEDULE 65 I B DRUGS, PHARMACEUTICALS, & HEMATOLOGY RELATED PRODUCTS, with a ceiling value of $25,000.00 and a period of performance through May 14, 2025. As a Federal Supply Schedule contract, this is a multiple award vehicle...